Biosynex SA (EPA:ALBIO)

Market Cap	31.08M
Revenue (ttm)	104.07M
Net Income (ttm)	-38.48M
Shares Out	18.75M
EPS (ttm)	-3.47
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,046
Average Volume	23,641
Open	1.510
Previous Close	1.500
Day's Range	1.510 - 1.660
52-Week Range	1.054 - 6.920
Beta	-1.74
RSI	59.16
Earnings Date	Apr 23, 2025

About Biosynex

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers medical devices for in vitro diagnosis in the form of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women’s health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers, oxymeters, and...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Employees: 569
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALBIO